Dr Rachel Nye Bies, MD | |
14001 Ridgedale Dr, Suite 100, Minnetonka, MN 55305-1753 | |
(952) 473-0211 | |
(952) 473-7908 |
Full Name | Dr Rachel Nye Bies |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 14001 Ridgedale Dr, Minnetonka, Minnesota |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386836443 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 50315 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rachel Nye Bies, MD 14001 Ridgedale Dr, Suite 100, Minnetonka, MN 55305-1753 Ph: (952) 473-0211 | Dr Rachel Nye Bies, MD 14001 Ridgedale Dr, Suite 100, Minnetonka, MN 55305-1753 Ph: (952) 473-0211 |
News Archive
Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).
A study in Biological Psychiatry has established a new analytical method for investigating the complex genetic origins of mental illnesses using brain cells that are grown in a dish from human embryonic stem cells.
Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors, today reported financial results for the first quarter ended March 31, 2010.
The New York Times takes a critical look at small military hospitals where the limited number of patients may compromise doctors' ability to treat serious problems. Other stories look at a surge in surgery prices and at programs to standardize children's surgical care.
AbbVie, a global biopharmaceutical company, today announced the European Medicines Agency has granted Orphan Drug Designation to venetoclax, an investigational, oral B-cell lymphoma-2 (BCL-2) inhibitor, for the treatment of acute myeloid leukemia (AML).
› Verified 8 days ago
Danah Marie O'neil, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 14001 Ridgedale Drive, Suite 100, Minnetonka, MN 55305 Phone: 952-473-0211 Fax: 952-473-7908 | |
Burton Allan Benson Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 14001 Ridgedale Dr Ste 100, Minnetonka, MN 55305 Phone: 952-473-0211 Fax: 952-473-7908 | |
Dr. Lorene Freehill, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 17705 Hutchins Dr, Suite 101, Minnetonka, MN 55345 Phone: 952-401-8300 | |
Mary Hobbs Meland, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 17705 Hutchins Dr, Minnetonka, MN 55345 Phone: 952-401-8300 | |
Dr. Tracy Goetz Hall, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 17705 Hutchins Dr, Minnetonka, MN 55345 Phone: 952-401-8300 | |
Dale Thomas Dobrin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 17705 Hutchins Dr Ste 101, Minnetonka, MN 55345 Phone: 952-401-8300 Fax: 952-401-8240 | |
Megan Bernadette Wong, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 17705 Hutchins Dr Ste 100, Minnetonka, MN 55345 Phone: 952-401-8300 Fax: 952-401-8242 |